Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
$1.40
+0 (+0%)
At Close: May 08, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Akebia Therapeutics Announces Change to Virtual Annual Meeting of Stockholders

 08:05pm, Thursday, 21'st May 2020
Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that due to the public health impact of

Akebia Therapeutics Inc (NASDAQ: AKBA) Q1 2020 Earnings Call Transcript | AlphaStreet

 05:03pm, Thursday, 21'st May 2020
Final earnings conference call transcript of Akebia Therapeutics Inc. - AKBA stock

Akebia Therapeutics Announces Full Exercise of Underwriters' Option to Purchase Additional Shares

 08:05pm, Tuesday, 19'th May 2020
Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that the underwriters of its previously

Tracking David Abrams' Abrams Capital Management Portfolio - Q1 2020 Update

 06:34am, Tuesday, 19'th May 2020
David Abrams’ 13F portfolio value decreased this quarter from $3.22B to $2.54B. The number of positions increased from 21 to 22. Abrams Capital Management added

Our Chief Picks In Pharma

 04:01am, Tuesday, 19'th May 2020
Recent results in Pharma show that there are some highly resilient plays for the COVID-19 environment. Now is a good time to take advantage of these extremely h

Akebia Therapeutics Announces Filing of a Supplemental New Drug Application for Riona in Japan for Treatment of Patients with Iron Deficiency Anemia

 12:04pm, Monday, 18'th May 2020

Akebia Therapeutics Announces Collaboration Partner's Submission of Supplemental New Drug Application for Use of Riona® (ferric citrate hydrate) to Treat Adult Patients with Iron Deficiency Anemia in Japan

 12:00pm, Monday, 18'th May 2020
Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company focused on the development and commercialization of therapeutics for people living with kidney disease, announced today that its c

Consonance Capital Management LP Buys Akebia Therapeutics Inc, Sarepta Therapeutics Inc, ...

 12:00am, Friday, 15'th May 2020

Akebia Therapeutics, Inc. (AKBA) Shares March Higher, Can It Continue?

 03:37pm, Wednesday, 13'th May 2020
As of late, it has definitely been a great time to be an investor in Akebia Therapeutics, Inc. (AKBA).

'This $AKBA short report reads dumb to me, like someone drank too much coffee and got overly stimulated for nothing. But I'm willing to listen to a saner interpretation and change my mind' -Tweet From STAT News' Adam Feuerstein

 04:23pm, Tuesday, 12'th May 2020

Akebia Therapeutics Shares Tick Lower Following Tweet From Short Seller Muddy Waters 'Our PRTA short opened our eyes to the...world of misleading presentation of biotech trial data. No view / no position on AKBA, but it does raise similar questions'

 03:30pm, Tuesday, 12'th May 2020

20 Healthcare Stocks Moving In Tuesday's Pre-Market Session

 11:33am, Tuesday, 12'th May 2020

32 Stocks Moving in Tuesday's Pre-Market Session

 11:16am, Tuesday, 12'th May 2020

5 Stocks To Watch For May 12, 2020

 08:42am, Tuesday, 12'th May 2020

Cara Therapeutics, Inc. (CARA) CEO Derek Chalmers on Q1 2020 Results - Earnings Call Transcript

 05:06am, Tuesday, 12'th May 2020
Cara Therapeutics, Inc. (NASDAQ:CARA) Q1 2020 Earnings Conference Call May 11, 2020 4:30 PM ET Company Participants Jack Hildick-Smith - Stern Investor Relation
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE